3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
18
Glioma
11
Neoplasms
6
Brain Neoplasms
6
Astrocytoma
6
Neuroblastoma
4
Sarcoma, Ewing
3
Gliosarcoma
3
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Pancreatic Neoplasms
2
Medulloblastoma
2
Diffuse Intrinsic Pontine Glioma
2
Wilms Tumor
1
Spinal Cord Neoplasms
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lymphoma, Follicular
1
Hepatoblastoma
1
Ganglioneuroblastoma
1
Interventions
lutetium Lu 177 dotatate
2
Magnetic Resonance Spectroscopy
2
olaparib
1
gallium Ga 68 dotatate
1
capivasertib
1
abemaciclib
1
Surveys and Questionnaires
1
Sunitinib
1
Specimen Handling
1
Lysine
1
Hydroxyurea
1
HhAntag691
1
Ga(III)-DOTATOC
1
GSK2256098
1
Everolimus
1
Bevacizumab
1
Arginine
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningioma
×
Temozolomide
×
30 days
×
Clear all
No trials found.